U.S. Software Stock News

Tucows (TCX) has just wrapped up FY 2025 with Q4 revenue of about US$98.7 million and a basic EPS loss of US$1.98, alongside a Q4 net loss of US$22.0 million. Over the past six quarters, revenue has moved from US$92.3 million in Q3 2024 to US$98.7 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$3.86 in Q4 2024 to a loss of US$1.98 in the latest quarter. Trailing twelve month EPS currently sits at a loss of US$6.85 on revenue of US$390.3 million as margins remain under...

Q1 2026 earnings snapshot Natural Grocers by Vitamin Cottage (NGVC) opened fiscal 2026 with Q1 revenue of US$335.6 million and basic EPS of US$0.49, setting the tone for its latest earnings update. The company reported revenue of US$330.2 million and EPS of US$0.43 in Q1 2025, compared with US$335.6 million and EPS of US$0.49 in Q1 2026. Trailing twelve month EPS stands at US$2.08 on revenue of about US$1.3 billion, with higher net profit margins and earnings growth framing the quarter as one...

E.W. Scripps (SSP) just reported FY 2025 fourth quarter results with revenue of US$560.3 million and basic EPS of US$0.51 loss, set against a year earlier fourth quarter that showed revenue of US$728.4 million and basic EPS of US$0.93. Over recent periods the company has seen quarterly revenue move from US$646.3 million and EPS of US$0.37 in 2024 Q3 to US$560.3 million and EPS of US$0.51 loss in 2025 Q4. Trailing 12 month revenue sits at about US$2.2 billion with basic EPS of US$1.87 loss...

Cerence (CRNC) opened Q1 2026 with total revenue of US$115.1 million, Basic EPS of a US$0.12 loss, and net income excluding extra items of a US$5.2 million loss, while the trailing 12 months show Basic EPS of roughly US$0.01 and net income excluding extra items of about US$0.3 million. Over recent quarters the company has seen revenue move from US$50.9 million in Q1 2025 to US$115.1 million in Q1 2026, alongside Basic EPS shifting from a US$0.57 loss to a US$0.12 loss and trailing 12 month...

Earnings turnaround puts Mercury General in focus Mercury General (MCY) is back on many investors’ radars after first quarter results showed revenue of US$1,539.81 million and net income of US$190.42 million, compared with a net loss a year earlier. See our latest analysis for Mercury General. The earnings rebound and steady dividend news have come alongside a 1 month share price return of 8.67% and a 1 year total shareholder return of 74.37%, which together point to solid momentum rather...

If you are wondering whether Sarepta Therapeutics at US$20.80 is starting to look like value or still carries too much risk, the recent share price and fundamentals give you a lot to weigh up. The stock has been under pressure, with returns of 0.4% decline over 7 days, 9.9% decline over 30 days, 2.4% decline year to date, 43.0% decline over 1 year and 82.7% decline over 3 years, while the 5 year return sits at 71.3% decline. Recent news around Sarepta Therapeutics has focused on its position...

National Health Investors (NYSE:NHI) is selling its entire skilled nursing facility portfolio for $560 million. The company plans to redeploy proceeds into private-pay senior housing, including a seven-property portfolio in Colorado. This shift reduces exposure to skilled nursing and increases focus on private-pay assets that management views as offering more attractive risk adjusted returns. For investors watching NYSE:NHI, this move comes with the stock recently closing at $75.07 and...

Pacific Biosciences of California (PACB) has just posted its FY 2025 numbers, with Q4 revenue at US$44.6 million and a basic EPS loss of US$0.13 set against trailing twelve month revenue of US$160.0 million and a TTM basic EPS loss of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue move between US$37.2 million and US$44.6 million, while basic EPS has ranged from a small profit of US$0.01 in FY 2024 Q4 to a loss of US$1.44 in FY 2025 Q1. This leaves...

Genius Sports (GENI) opened Q1 2026 with revenue of US$188 million, a basic EPS loss of US$0.21 per share, and net income loss of US$55 million, setting a cautious tone around near term profitability. The company has seen quarterly revenue move from US$144 million in Q1 2025 to US$188 million in Q1 2026, while basic EPS shifted from a loss of US$0.03 to a loss of US$0.21 over the same period. This puts the focus squarely on how efficiently that extra revenue is translating into results. For...

Why National Storage Affiliates Trust is on investors’ radar National Storage Affiliates Trust (NSA) has drawn attention after its recent share performance, with the stock showing positive returns over the past week, month and past 3 months. This has invited closer inspection from income focused REIT investors. See our latest analysis for National Storage Affiliates Trust. While the 1 day share price return was slightly negative, the recent 30 day and year to date share price returns of...

In early May 2026, NIKE, Inc.’s board declared a quarterly cash dividend of US$0.41 per share on its Class A and Class B common stock, payable on July 1, 2026, to shareholders of record as of June 1, 2026. The dividend decision comes as Nike faces analyst downgrades, business headwinds, and legal and regulatory scrutiny that are testing confidence in its turnaround plan. Next, we’ll examine how Wells Fargo’s downgrade, tied to weaker athletic footwear demand and global challenges, reshapes...

ACADIA Pharmaceuticals (ACAD) opened 2026 with Q1 revenue of $268.1 million and basic EPS of $0.02, against a backdrop of trailing twelve month revenue of $1.1 billion, basic EPS of $2.22 and net income of $375.7 million. Over recent quarters, the company has seen revenue move from $244.3 million in Q1 2025 to $268.1 million in Q1 2026, while quarterly basic EPS has ranged from $0.11 to $1.62. These results come within a period of margin expansion and earnings growth that investors now need...

If you are wondering whether Ouster's share price still offers value after a strong run, it helps to start by lining up the recent returns with what the current valuation really implies. Ouster's stock closed at US$24.51, with returns of 26.8% over 30 days, 4.9% year to date and 183.4% over 1 year, while the last 7 days show a 9.1% decline and the 5 year figure sits at a 70.9% loss. Taken together, these figures suggest investors have been reassessing both potential and risk over different...

In early May 2026, Erie Indemnity reported first-quarter results that fell short of analyst expectations on both earnings per share and revenue, coinciding with its shares touching a fresh 52-week low. Despite this disappointment and a roughly US$2.30 billions reduction in market value over a recent losing streak, a premarket rebound suggested some investors still saw positives in the company’s underlying performance. With recent earnings missing forecasts and raising questions about...

This article considers whether Coinbase Global's recent share price suggests a potential bargain or already reflects its current story, by comparing its value against several common yardsticks. At a last close of US$192.96, the stock has returned 2.8% over the past week and 10.1% over the past month. It is down 18.4% year to date and has returned 219.7% over three years and 27.2% over five years. Recent headlines around Coinbase Global have focused on its role as a listed gateway to crypto...

In early May 2026, V2X, Inc. completed a US$149.04 million follow-on common stock offering at US$74.35 per share, shortly after reporting first-quarter sales of US$1,254.13 million and net income of US$18.93 million, and increasing its full-year 2026 revenue guidance to a range of US$4.83 billion to US$4.98 billion. The company’s roughly US$4.10 billion in new awards and record US$13.80 billion backlog highlight how recent contract wins are shaping management’s more confident outlook and...

Warner Music Group and Paramount Pictures have agreed a multi year, first look partnership to develop theatrical films based on Warner Music artists and songwriters. The deal focuses on creating new cinema projects that tap into both legendary and contemporary acts from Warner Music Group. This collaboration pairs a major recorded music company with a leading Hollywood studio to build film concepts around music IP. For investors watching NasdaqGS:WMG, this new film partnership sits...

If you are wondering whether Regeneron Pharmaceuticals at around US$709.10 is priced attractively or already reflects the story, the valuation picture is where the answers start to emerge. The stock is up 0.3% over the last 7 days, while it shows a 6.7% decline over 30 days, an 8.7% decline year to date, and a 30.2% return over the past year, which can change how investors think about both upside potential and risk. Recent headlines around Regeneron often focus on its position within large...

Atlassian (NasdaqGS:TEAM) has launched major AI native platform upgrades, highlighted by the open Teamwork Graph and new autonomous agent capabilities. The new features, including agents in Rovo and Jira, are designed to help teams plan, execute, and automate work across Atlassian and third party tools. Governance and security controls are built into the platform, targeting enterprise use cases where data access and compliance are critical. Atlassian is best known for tools like Jira and...

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...

Floor & Decor Holdings (FND) has come into focus after releasing first quarter results, issuing full year 2026 guidance, outlining plans for 20 new warehouse stores, and announcing a new US$400 million share repurchase program. See our latest analysis for Floor & Decor Holdings. The recent earnings release, new 2026 guidance, planned 20 warehouse openings and US$400 million buyback have coincided with short term momentum, with a 7 day share price return of 6.45% and 1 month share price return...

Cognyte Software Ltd. previously announced a three-year subscription contract worth over US$20,000,000 with a long-standing EMEA-region customer, expanding deployment of its AI-driven analytics to handle higher data volumes and more complex investigations. The shift of this long-term relationship to a subscription model underscores recurring revenue visibility and deeper integration of Cognyte’s capabilities into mission-critical operations. Next, we’ll explore how this expanded, multi-year...

Aflac Incorporated recently reported first-quarter 2026 results, with revenue rising to US$4.35 billion and net income to US$1.02 billion, while also continuing share repurchases, maintaining its quarterly dividend, and opening a new claims office in South Portland to support Maine’s Paid Family and Medical Leave program that began paying benefits on May 1. Despite this combination of earnings growth, capital returns, and expansion into state-administered leave programs, management...

If you are wondering whether AECOM's share price reflects its true value, you are not alone. This article focuses squarely on what the current price might be asking you to pay. The stock last closed at US$81.47, with returns of a 3.1% decline over 7 days, 2.2% decline over 30 days, 15.5% decline year to date and 21.1% decline over the past year, set against longer term returns of 7.8% over 3 years and 26.4% over 5 years. Recent coverage has centered on how investors are reassessing...